million, respectively. The decrease was primarily due to the increase of Medical personnel to support its expansion included administrative expenses to prepare for listing on the Stock Exchange of Thailand
% respectively, which decreased by 4.0%. The decrease was primarily due to the more effective internal control system of The Company. Financing Costs The Company and its subsidiary ‘s financing costs in relation
Public Company Limited (“the company”) held on 19 March, 2017 has approved the company to change the core business to property development. Thus, the Extraordinary General Meeting of Shareholders, held on
56%, respectively mainly due to the increase of income coupled with the decrease of financing cost. In addition, during 1Q17, its subsidiary (Rajthanee Rojana Hospital Co., Ltd.) has recognized income
at 16.20% and 11.75% in the six-month period ended June 30, 2018 and the six-month period ended June 30, 2019, respectively. The period-on-period decrease in net profit to revenue ratio was because of
profits by 12.5% as a result of higher efficiency gains from effective cost controls, despite a decrease in total revenue by 3.4% primarily due to the decline in revenue from sales, consistent with the
expenses for the year 2017 and 2016 amounting to THB 868 million and THB 983 million, respectively, (Separate: THB 341 million and THB 454 million, respectively), decrease by THB 115 million (Consolidated
amounting to THB 868 million and THB 983 million, respectively, (Separate: THB 341 million and THB 454 million, respectively), decrease by THB 115 million (Consolidated) and THB 113 million (Separate). The
quarter by THB 721 million due to; - Decreased HRC price: the average selling price of HRC in Q2-2017 was THB 17,252/ton, decreased by 9% as compared with Q1-2017 (THB 18,907/ton) due to the decrease in HRC
2017 Change MB % MB % MB % Cash and cash equivalents 844 6.5% 796 4.8% -48 -5.7% Trade and other receivables 355 2.7% 279 1.7% -76 -21.4% Inventories 1,149 8.8% 2,006 12.2% 857 74.6% Property Development